Qi Wang
Fortuna: 1 M $ al 31/08/2026
Fortuna: 1 M $ al 31/08/2026
Qi Wang is currently Chief Financial Officer & Deputy General Manager at Gan & Lee Pharmaceuticals Co., Ltd. since 2026.
Education history includes graduate studies at Shanghai Jiao Tong University and undergraduate studies at Shanghai University of Finance & Economics.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 27/07/2026 | 100.000 ( 0,28 % ) | 1 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GAN & LEE PHARMACEUTICALS. | Director Financiero/CFO | 09/03/2026 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Shanghai Jiao Tong University
Shanghai Jiao Tong University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai University of Finance & Economics
Shanghai University of Finance & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gan & Lee Pharmaceuticals Co., Ltd.
Gan & Lee Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes human therapeutics | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.